New Treatment for Rheumatoid Arthritis Granted FDA Approval - Pharmacy Times
New Treatment for Rheumatoid Arthritis Granted FDA Approval Pharmacy Times
Officials with the FDA have approved AbbVie's upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with ...
Comments
Post a Comment